According to Fortune Business Insights, the global next-generation sequencing (NGS) market size was valued at USD 10.44 billion in 2025 and is projected to reach USD 38.34 billion by 2034, expanding at a CAGR of 15.88% during the forecast period. North America dominated the market with a share of 56.01% in 2025, supported by strong genomic research infrastructure, high healthcare spending, and extensive adoption of advanced sequencing technologies.
Next-generation sequencing is a high-throughput DNA and RNA sequencing technology that enables rapid and cost-effective genetic analysis. NGS is widely used in clinical diagnostics, drug discovery, oncology, genetic disease testing, and biomedical research, transforming modern healthcare and life sciences research.
MARKET DYNAMICS
Market Drivers
Rising Adoption of Precision Medicine and Genomic Research
The increasing use of genomic information for personalized treatment planning and disease diagnosis is significantly driving market growth.
Market Restraints
High Cost of Sequencing Systems and Data Analysis
Advanced sequencing instruments and bioinformatics infrastructure require substantial investment, limiting accessibility for smaller institutions.
Market Opportunities
Expansion of Clinical Applications and Liquid Biopsy Technologies
Growing use of NGS in oncology, reproductive health, infectious disease testing, and non-invasive diagnostics is creating strong growth opportunities.
Market Challenges
Complexity of Data Interpretation and Regulatory Compliance
Managing large genomic datasets and ensuring regulatory compliance remain major challenges for healthcare providers and laboratories.
Get Free Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/next-generation-sequencing-ngs-market-101000
NEXT-GENERATION SEQUENCING MARKET TRENDS
Increasing Adoption of Long-Read and Real-Time Sequencing Technologies
Technologies such as nanopore sequencing are gaining traction due to faster analysis, portability, and improved genomic accuracy.
SEGMENTATION ANALYSIS
By Type
The market includes products and services.
Products
- Instruments
- Consumables
Consumables dominate the market due to recurring demand for reagents, kits, and sequencing materials used in routine testing and research.
Services
Sequencing and bioinformatics services are growing rapidly due to increasing outsourcing by research institutions and healthcare providers.
By Technology
Technologies include sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing, and others.
- Sequencing By Synthesis (SBS): Dominates the market due to high accuracy, scalability, and widespread use in research and clinical applications.
- Nanopore Sequencing: Growing rapidly due to portability and real-time sequencing capabilities.
- ION Semiconductor Sequencing: Used in targeted sequencing and rapid diagnostic applications.
By Application
Applications include research & applied and clinical applications.
Clinical Applications
- Cardiovascular
- Oncology
- Genetic Diseases
- Reproductive Health
Oncology dominates the clinical segment due to increasing use of genomic profiling for cancer diagnosis and targeted therapy development.
By End User
End users include pharmaceutical & biotechnology companies, academic & research institutes, and others. Pharmaceutical and biotechnology companies dominate the market due to increasing genomic drug development and precision medicine research activities.
REGIONAL ANALYSIS
North America
North America dominates the market due to advanced healthcare infrastructure, strong genomic research funding, and widespread adoption of precision medicine technologies.
Europe
Europe is witnessing steady growth driven by government support for genomics research and increasing use of NGS in clinical diagnostics.
Asia Pacific
Asia Pacific is expected to grow rapidly due to expanding biotechnology industries, rising healthcare investments, and increasing genomic research initiatives.
Latin America
Latin America is experiencing gradual growth supported by improving healthcare diagnostics infrastructure and research capabilities.
Middle East & Africa
The Middle East & Africa region is witnessing moderate growth due to increasing adoption of molecular diagnostics and personalized healthcare solutions.
Get Free Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/next-generation-sequencing-ngs-market-101000
COMPETITIVE LANDSCAPE
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies plc
- BGI Genomics Co., Ltd.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN N.V.
- PerkinElmer Inc.
- Bio-Rad Laboratories, Inc.
REPORT COVERAGE
The next-generation sequencing market report provides insights into market size, segmentation, regional outlook, and competitive landscape. It highlights trends such as precision medicine, long-read sequencing, and genomic diagnostics. Increasing use of genomics in clinical care and biomedical research is expected to drive substantial market growth during the forecast period.